Lyell Immunopharma, Inc.
NASDAQ:LYEL
1.27 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 133.424 | 125.65 | 145.647 | 286.214 | 224.372 | 109.426 | 123.554 | 116.311 | 205.739 | 222.596 | 293.828 | 393.504 | 564.441 | 244.37 | 140.406 | -436.049 |
| Short Term Investments
| 357.695 | 400.65 | 400.576 | 289.217 | 371.376 | 503.343 | 516.598 | 531.821 | 449.825 | 391.316 | 320.966 | 225.417 | 260.082 | 360.563 | 472.213 | 872.098 |
| Cash and Short Term Investments
| 491.119 | 526.3 | 546.223 | 575.431 | 595.748 | 612.769 | 640.152 | 648.132 | 655.564 | 613.912 | 614.794 | 618.921 | 824.523 | 604.933 | 612.619 | 436.049 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 8.705 | 7.865 | 8.463 | 11.423 | 10.662 | 11.629 | 11.143 | 11.613 | 11.214 | 11.793 | 11.492 | 12.226 | 10.317 | 4.802 | 4.928 | 0 |
| Total Current Assets
| 499.824 | 534.165 | 554.686 | 586.854 | 606.41 | 624.398 | 651.295 | 659.745 | 666.778 | 625.705 | 626.286 | 631.147 | 834.84 | 609.735 | 617.547 | 436.049 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 130.792 | 136.531 | 142.317 | 148.699 | 155.189 | 160.99 | 166.265 | 169.811 | 172.466 | 171.432 | 166.639 | 163.093 | 158.061 | 144.874 | 124.055 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 19.287 | 19.286 | 48.507 | 54.73 | 68.953 | 90.179 | 115.041 | 144.52 | 178.439 | 271.119 | 330.532 | 400.959 | 233.709 | 118.652 | 163.443 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.239 | 4.238 | 4.519 | 4.706 | 4.802 | 4.883 | 4.96 | 3.193 | 3.991 | 3.847 | 3.949 | 3.135 | 3.257 | 3.928 | 3.235 | -436.049 |
| Total Non-Current Assets
| 154.318 | 160.055 | 195.343 | 208.135 | 228.944 | 256.052 | 286.266 | 317.524 | 354.896 | 446.398 | 501.12 | 567.187 | 395.027 | 267.454 | 290.733 | -436.049 |
| Total Assets
| 654.142 | 694.22 | 750.029 | 794.989 | 835.354 | 880.45 | 937.561 | 977.269 | 1,021.674 | 1,072.103 | 1,127.406 | 1,198.334 | 1,229.867 | 877.189 | 908.28 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 4.199 | 4.895 | 4.817 | 4.365 | 5.805 | 5.733 | 3.917 | 4.795 | 4.247 | 6.51 | 3.207 | 3.526 | 4.863 | 7.121 | 9.396 | 0 |
| Short Term Debt
| 6.898 | 6.667 | 6.273 | 6.061 | 5.853 | 4.81 | 4.534 | 0 | 21.396 | 0 | 1.169 | 25.058 | 25.568 | 26.035 | 3.617 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 20.36 | -6.061 | -5.853 | -4.81 | 21.869 | 11.191 | 15.426 | 6.224 | 4.988 | 5.581 | 8.226 | 7.916 | 6.095 | 0 |
| Other Current Liabilities
| 19.782 | 20.791 | 3.069 | 30.699 | 28.585 | 25.064 | 6.708 | 35.231 | 9.222 | 28.321 | 37.374 | 25.116 | 25.006 | 15.74 | 30.177 | 0 |
| Total Current Liabilities
| 30.879 | 32.353 | 34.519 | 35.064 | 34.39 | 30.797 | 37.028 | 51.217 | 50.291 | 41.055 | 46.738 | 59.281 | 63.663 | 56.812 | 49.285 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 53.323 | 55.159 | 56.894 | 58.576 | 60.221 | 61.826 | 63.168 | 64.636 | 66.074 | 67.475 | 66.65 | 65.684 | 61.471 | 57.756 | 50.957 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.163 | 32.927 | 77.871 | 79.665 | 81.883 | 81.878 | 84.808 | 89.066 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.439 | 3.551 | 3.664 | 3.776 | 3.888 | 4.001 | 4.113 | 4.227 | 4.34 | 4.453 | 4.566 | 5.012 | 0.9 | 0.893 | 0.532 | 0 |
| Total Non-Current Liabilities
| 56.762 | 58.71 | 60.558 | 62.352 | 64.109 | 65.827 | 67.281 | 106.026 | 103.341 | 149.799 | 150.881 | 152.579 | 144.249 | 143.457 | 140.555 | 0 |
| Total Liabilities
| 87.641 | 91.063 | 95.077 | 97.416 | 98.499 | 96.624 | 104.309 | 157.243 | 153.632 | 190.854 | 197.619 | 211.86 | 207.912 | 200.269 | 189.84 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,198.334 | 1,229.867 | 1,010.968 | 1,010.968 | 519.163 |
| Common Stock
| 0.026 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.024 | 0.024 | 0.024 | 0.002 | 0.002 | 0 |
| Retained Earnings
| -1,108.588 | -1,062.779 | -1,002.112 | -949.182 | -898.329 | -834.439 | -767.48 | -759.083 | -688.829 | -652.506 | -584.362 | -500.656 | -451.781 | -389.186 | -334.143 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -0.397 | -0.404 | -0.094 | -1.181 | -2.379 | -3.879 | -7.599 | -9.996 | -8.351 | -6.6 | -1.623 | -0.065 | 0.073 | 0.163 | 0.256 | -111.108 |
| Other Total Stockholders Equity
| 1,675.46 | 1,666.315 | 1,657.133 | 1,647.911 | 1,637.538 | 1,622.119 | 1,608.306 | 1,589.08 | 1,565.197 | 1,540.33 | 1,515.748 | 288.837 | 243.772 | 54.973 | 41.357 | 0 |
| Total Shareholders Equity
| 566.501 | 603.157 | 654.952 | 697.573 | 736.855 | 783.826 | 833.252 | 820.026 | 868.042 | 881.249 | 929.787 | 986.474 | 1,021.955 | 676.92 | 718.44 | 408.055 |
| Total Equity
| 566.501 | 603.157 | 654.952 | 697.573 | 736.855 | 783.826 | 833.252 | 820.026 | 868.042 | 881.249 | 929.787 | 986.474 | 1,021.955 | 676.92 | 718.44 | 408.055 |
| Total Liabilities & Shareholders Equity
| 654.142 | 694.22 | 750.029 | 794.989 | 835.354 | 880.45 | 937.561 | 977.269 | 1,021.674 | 1,072.103 | 1,127.406 | 1,198.334 | 1,229.867 | 877.189 | 908.28 | 408.055 |